Table 1.

Subject characteristics

Parameter/statisticsGTDS group 1 (N = 60)Intravenous granisetron group 2 (N = 60)Placebo group 3 (N = 60)Moxifloxacin group 4 (N = 60)Total (N = 240)
Age, y
 Mean (SD)29.9 (9.01)30.3 (8.51)29.7 (8.63)29.0 (9.32)29.7 (8.83)
 Min, max18, 4618, 4818, 4818, 4918, 49
Gender, n (%)
 Male30 (50.0)31 (51.7)29 (48.3)29 (48.3)119 (49.6)
 Female30 (50.0)29 (48.3)31 (51.7)31 (51.7)121 (50.4)
Race, n (%)
 White33 (55.0)36 (60.0)41 (68.3)28 (46.7)138 (57.5)
 African-American19 (31.7)21 (35.0)15 (25.0)23 (38.3)78 (32.5)
 Other8 (13.3)3 (5.0)4 (6.7)9 (15.0)24 (10.0)
Weight, kg
 Mean (SD)73.37 (11.508)73.42 (12.104)73.14 (9.982)72.55 (10.797)73.12 (11.061)
 Min, max50.1, 97.650.1, 100.551.4, 101.050.3, 96.850.1, 101.0